Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data.
Voice-related quality of life in patients with multiple sclerosis.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.
Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation.
Multiple sclerosis: IgM bands indicate reduced risk of PML on natalizumab.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction.
Direct effects of secretory products of immune cells on neurons and glia.
Erratum to: Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?
Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
Signaling networks in MS: A systems-based approach to developing new pharmacological therapies.
Neuroantigen-Specific Autoregulatory CD8+ T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function.
The essential role of t cells in multiple sclerosis: A reappraisal.
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Multiple sclerosis eye-brain dynamic correlation.
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
Vagus somatosensory-evoked potentials are prolonged in patients with multiple sclerosis with brainstem involvement.
Platelets and autoimmunity.
NAD(+) protects against EAE by regulating CD4(+) T-cell differentiation.
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity.
Pages
« first
‹ previous
…
335
336
337
338
339
340
341
342
343
…
next ›
last »